Skip to main content
Equibles

HLN · Haleon plc · Metrics

Track HLN — free

Use HLN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HLN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.02 -0.15 (-1.47%) At close · Oct 21
Rebalance outlook locked
Market Cap
$44.06B
Shares
4.40B
Volume · Oct 21 13.01M Avg daily vol (3M) 14.98M

HLN metrics

83 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.02
Market cap
$44.06B

Price action

20 metrics
Price change (1W)
+3.5%
Price change (30D)
+8.3%
Price change (3M)
+1.7%
Price change (6M)
+7.1%
Price change (YTD)
-0.9%
Price change (1Y)
+7.4%
Trailing year
Price change (5Y)
—
52-week high
$11.27
52-week low
$8.70
Change from 52-week high
-11.1%
Change from 52-week low
+15.2%
Annualized volatility
23.2%
Annualized volatility (3M)
23.0%
Beta
-0.1
RSI (14D)
65.2
Price vs SMA 50
+5.0%
Price vs SMA 200
+2.5%
Avg volume (3M)
14.98M
Relative volume
0.9
Average dollar volume
$142.99M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
4.40B

Valuation

12 metrics
P / E (TTM)
20.5
Trailing earnings · reciprocal yield 4.9%
PEG ratio
1.2
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.0×
reciprocal yield 33.5%
P / book
2.1
reciprocal yield 48.6%
FCF yield
6.9%
TTM · current market cap
Buyback yield
—
P / FCF
14.4
reciprocal yield 6.9%
P / operating cash flow
12.6
reciprocal yield 8.0%
Earnings yield
4.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.9%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.20
Dividend growth YoY
+10.8%
Dividend growth streak
2
Last ex-dividend
2026-08-14

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
65.0%
Operating margin
21.4%
Trailing 12 months
Net margin
14.6%
Gross profit (TTM)
$7.25B
Operating profit (TTM)
$2.38B
Net income (TTM)
$2.18B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
20.8%
Effective tax rate
23.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-1.8%
Year over year
Net income growth YoY
+15.6%
Revenue (TTM)
$14.97B
Trailing 12 months
EPS growth YoY
+17.8%
Shares change YoY
-1.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+0.5%
Revenue CAGR (5Y)
+2.2%
EPS CAGR (3Y)
+17.2%
EPS CAGR (5Y)
+8.3%
FCF CAGR (3Y)
+9.5%
FCF CAGR (5Y)
+14.3%

Quality

14 metrics
Return on equity
9.9%
Return on assets
5.0%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
—
Free cash flow (TTM)
$3.11B
Quick ratio
0.5
Interest coverage
7.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.10B
Total assets
$43.20B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.56B
Capital expenditures (TTM)
$451.05M
R&D (TTM)
$421.52M
SG&A (TTM)
—
Stock compensation (TTM)
$130.21M
R&D / revenue
2.8%
Stock compensation / revenue
0.9%

Ownership (13F)

9 metrics
13F filers
650
13F filer change QoQ
+20
Institutional ownership
13.4%
Conviction holders (share of 13F filers)
0.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.2%
Holder tenure
13.6
Price vs estimated holder cost
+11.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.1%

Short interest

3 metrics
Short interest
0.6%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1900304 CUSIP 405552100 13F (30d) 131 filings 117 filers Visit website Investor relations